The Foreign Investment Promotion Board (FIPB) will take up 47 proposals of foreign investment on Monday, including those of pharmaceutical majors like Glaxo SmithKline, Novartis and Mylan Laboratories. FDIs for proposals in sensitive segments have to be first granted by the FIPB. The board can also recommend proposals of up to Rs 3,000 crore to the finance minister for approval.